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SUMMARY
Evidence suggests that distinct splenic dendritic cell
(DC) subsets activate either CD4+ or CD8+ T cells
in vivo. This bias has been partially ascribed to differ-
ential antigen presentation; however, all DC subsets
can activate both T cell lineages in vitro. Therefore,
we tested whether the organization of DC and T cell
subsets in the spleen dictated this preference. We
discovered that CD4+ and CD8+ T cells segregated
within splenic T cell zones prior to immunization. Af-
ter intravenous immunization, the two major conven-
tional DC populations, distinguished by 33D1 and
XCR1 staining, migrated into separate regions of
the T cell zone: 33D1+ DCs migrated into the CD4+
T cell area, whereas XCR1+ DCs migrated into the
CD8+ T cell area. Thus, the post-immunization loca-
tion of each DC subset correlated with the T cell line-
age it preferentially primes. Preventing this co-local-
ization selectively impaired either CD4+ or CD8+
T cell immunity to blood-borne antigens.
INTRODUCTION
Activation of naive T lymphocytes is the first step in the induction
of most adaptive immune responses, such as those to vaccines
or pathogens. Given that this key step dictates a metabolically
costly and potentially deleterious cascade of cellular events, it
is not surprising that a coordinated series of checkpoints exist
to regulate naive T cell priming. One crucial checkpoint is antigen
presentation. This is accomplished primarily by mature dendritic
cells (DCs) not only because they express the requisite stimula-
tory signals to activate naive T cells, but also because, after an-
tigen capture from tissues and maturation by an innate immune
stimulus, they efficiently migrate via lymphatics to draining
lymph nodes (LNs) (Itano and Jenkins, 2003); circulation of naive
T cells is restricted to such secondary lymphoid organs.
For blood-borne antigens, this entire process occurs in the
spleen, which, unlike all other secondary lymphoid structures,
does not contain afferent lymphatics (Bronte and Pittet, 2013).
The spleen filters the blood of aging red blood cells (RBCs), as
well as foreign antigens or pathogens that have gained access
to the bloodstream. It is divided by function and structure into
red pulp (RP) and white pulp (WP); between these two regions
is the marginal zone (MZ) in mice or the perifollicular zone in hu-
mans (Mebius and Kraal, 2005). Most lymphocytes are located in
the WP and reside in distinct zones, such as the T cell zone,
where T lymphocytes are concentrated. The WP is where adap-
tive immune responses are generated to blood-borne antigens.
DCs are the primary cells in the spleen that prime T cells to an-
tigens encountered in the blood (Meredith et al., 2012). Although
the migration of tissue DCs to draining LNs is known to be a
crucial step in the induction of T cell responses, it is not clear
that the same holds true within the spleen (Czeloth et al., 2005;
Ohl et al., 2004). The presence of CD8+ DCs in the T cell zone
at steady state in both humans and mice (Idoyaga et al., 2009;
Pack et al., 2008) raises the possibility that antigen transport
via DC migration might not be necessary, unlike in other sites
in the body, because the unique architecture of the spleen
juxtaposes the antigen-exposed tissue (e.g., the MZ) with the
lymphoid compartment (e.g., the WP) (Bronte and Pittet, 2013;
Khanna et al., 2007). Indeed, the role of the primary DC homing
receptor to LNs, CCR7, in DC movement within the spleen is
debated (Czeloth et al., 2005; Gunn et al., 1999; Ritter et al.,
2004; Yi and Cyster, 2013). However, the same kinds of innate
stimuli that induce tissue DCs to migrate to LNs are also stimuli
of DC migration within the spleen (Bala´zs et al., 2002; De Smedt
et al., 1996; De Trez et al., 2005; Idoyaga et al., 2009; Reis e
Sousa and Germain, 1999). If this relocalization is not necessary
for adaptive immunity, then how is a threshold created to prevent
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T cell activation to innocuous or self-antigens in the blood? We
aimed to characterize how particular splenic DCs migrate
following immunization and howmigration impacts the activation
of each T cell lineage.
In the mouse spleen, DCs are divided into plasmacytoid DCs
(pDCs), conventional DCs (cDCs), and monocyte-derived DCs
such as TNFa-iNOS-producing (TIP) DCs (Serbina et al., 2003).
cDCs are the primary cells that activate naive T cells and can
be further divided into two main subsets based on transcription
factor usage, surface marker expression, and the ability to prime
CD4+ versus CD8+ T cells (Guilliams et al., 2014; Meredith et al.,
2012; Satpathy et al., 2012; Segura and Amigorena, 2013). The
Irf4-dependent cDC subset efficiently processes antigen for ma-
jor histocompatibility complex class II (MHCII) and preferentially
primes CD4+ T cells; almost all are marked by 33D1, SIRPa, and
CD11b in the spleen, with variable expression of CD4 and ESAM
(Dudziak et al., 2007; Pooley et al., 2001; Suzuki et al., 2004). In
contrast, Batf3-dependent XCR1+CD8aa+ cDCs readily cross-
present phagocytosed antigen on MHC class I (MHCI) to CD8+
T cells (den Haan et al., 2000; Hildner et al., 2008; Pooley
et al., 2001; Schnorrer et al., 2006; Schulz and Reis e Sousa,
2002). This subset is also dependent on the transcription factor
IRF8 and includes DCs that express DEC205 or CD103 (Hildner
et al., 2008; Qiu et al., 2009).
Depending on the study, the preferential activation of CD4+
versus CD8+ T cells by the two cDC subsets is determined by
differential antigen acquisition, cytokine elaboration, or the abil-
ity to present a given antigen on MHCI versus MHCII (Dudziak
et al., 2007; Maldonado-Lo´pez et al., 1999; Pulendran et al.,
1999; Schulz and Reis e Sousa, 2002). These functional distinc-
tions are not strict, in that both DC subsets can activate, albeit
with different efficiency, CD4+ and CD8+ T cells when placed
in vitro. Therefore, an absolute presence versus absence of
MHCI or -II machinery on different DCs does not exist (Kam-
phorst et al., 2010; Maldonado-Lo´pez et al., 1999; Pulendran
et al., 1999; Schnorrer et al., 2006; Schulz and Reis e Sousa,
2002). For example, mice lacking CD11b+ splenic DCs second-
ary to the deletion of the Notch2 receptor have defective CD4+
T cell activation in vivo, but when DCs from these same mice
were used to stimulate CD4+ T cells in vitro, no apparent defect
was observed (Lewis et al., 2011). Therefore, although ample ev-
idence suggests that 33D1+ DCs preferentially prime CD4+
T cells, whereas XCR1+ DCs preferentially prime CD8+ T cells
in vivo, why this preference exists is not clear, given that,
in vitro, they are functionally similar. Since this preference has
been primarily established in vivo, we hypothesized that the or-
ganization of DC and T cell subsets in the spleen determines
this preference.
We found that CD4+ and CD8+ T cells preferentially occupy
different areas of the T cell zone at steady state. Furthermore,
we found that DCmigration within the spleen is triggered bymul-
tiple forms of intravenous (i.v.) immunization, including RBC
transfusion, and requires DC-intrinsic CCR7. Therefore, we
tested whether in vivo functional DC specialization could be
explained by the spatial segregation of migratory DCs within
the spleen during an immune response. By combining immuno-
fluorescence microscopy using recently identified DC subset
markers with in vivo flow-cytometry-based cell tracking, we
discovered that the two major DC subsets segregated into
non-overlapping regions of the T cell zone. 33D1+ DCs migrated
to the periphery of the T cell zone (bordering the B cell area),
whereas MZ XCR1+ DCs migrated into the center of the T cell
zone. Thus, the post-immunization location of each DC subset
correlates with the T cell it most efficiently primes. By defining
the T cell response in vivo rather than in vitro, we elucidated
how movement of individual DC subsets selectively generates
a CD4+ versus CD8+ T cell response to blood-borne antigens.
RESULTS
33D1+ and XCR1+ DC Subsets Survey Different Regions
of the Spleen for Antigen at Steady State
To identify the two primary cDC subsets by flow cytometry and
immunofluorescence, we stained for XCR1 (the chemokine re-
ceptor for XCL1) and for the C-type lectin receptor DCIR2 (DC-
inhibitory receptor 2) with the antibody 33D1. Unlike other subset
markers such as CD8a or CD11b, these markers are unique to
DCs, do not stain T cells or other myeloid populations, and
detect almost all cDCs in the spleen (Figure S1A) (Dorner et al.,
2009; Dudziak et al., 2007; Yi and Cyster, 2013). Using these
markers and the staining of MZ metallophilic macrophages
(Chang et al., 1995) with MOMA-1 (anti-CD169) to delineate
the WP border (Figure 1A), we found that the two primary DC
subsets segregated at steady state (Figures 1B–1E) (Idoyaga
et al., 2009; Pack et al., 2008; Yi and Cyster, 2013). Consistent
with previous reports, 33D1+ DCs are concentrated in the
bridging channel (Figures 1B and 1D) (Yi and Cyster, 2013), a
unique region of the spleen that spans the interface between
the RP and WP and can be identified by a break in MOMA-1
staining (Figures 1A and 1D). It was originally believed that
CD8+ DCs were solely located within the T cell zone of the
WP, based on DEC205 staining (Pack et al., 2008). However,
DEC205 is not expressed on all CD8+ DCs; the recent identifica-
tion of XCR1 as a subset-defining marker for CD8+ and CD103+
DCs in multiple tissues facilitated the tracking of all splenic DCs
within this subset, including those from the MZ (Crozat et al.,
2011; Dorner et al., 2009). We found that the majority of
XCR1+ DCs are located in the RP/MZ at steady state (Figures
1C and 1E) and that only about 30% of CD8+XCR1+ DCs reside
in the WP at steady state (Figure 2A). This finding is consistent
with more recent work demonstrating that some XCR1+ DCs—
in particular, those marked by CD103 or langerin—reside in the
MZ (Alexandre et al., 2016; Dorner et al., 2009; Idoyaga et al.,
2009; Qiu et al., 2009). This configuration may enable the two
cDC subsets to survey distinct regions of the spleen for potential
antigens, analogous to distinct regions scanned by particular
cDC subsets in LNs (Gerner et al., 2015).
33D1+ andXCR1+DCsMove into Distinct Regions of the
T Cell Zone following Immunization
We sought to address whether only particular DC subsets
migrate within the spleen and the effect of DC migration on
T cell priming to bloodborne antigens. We chose two models
to study systemic immunization: (1) the CD4+ andCD8+ T cell re-
sponses to an i.v. soluble protein, ovalbumin (OVA), in the pres-
ence of an innate stimulus, lipopolysaccharide (LPS); and (2) the
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CD4+ T-dependent alloantibody response to transfused RBCs.
Despite matching the ABO blood group antigens, approximately
3% of all transfusion recipients and up to 45% of patients
requiring chronic transfusion generate alloantibodies against mi-
nor antigens on RBCs, with potentially detrimental outcomes,
such as hemolysis and renal failure (Tormey et al., 2008; Vichin-
sky et al., 1990). Unlike previous studies using xenogeneic sheep
RBCs, we used a model to study the alloimmune response to
foreign antigens on transfused murine RBCs: transgenic
‘‘HOD’’ RBCs expressing a membrane-bound, allogeneic anti-
gen incorporating hen egg lysozyme (HEL), OVA, and Duffyb
(Hendrickson et al., 2011). This facilitates antigen tracking and
uptake by different cell populations in the spleen, along with
themeasurement of RBC-specific T and B cell responses in vivo.
When RBCs from HOD transgenic mice are collected and stored
in human anticoagulant solutions, processed to remove leuko-
cytes, and transfused into congenic recipients, they induce a
rapid innate anddelayedadaptive immune response (Figure S2A)
Figure 1. 33D1+ and XCR1+ DC Subsets
Survey Different Regions of the Spleen
(A) Fluorescence image of a spleen from a naive
wild-type mouse highlighting splenic architecture.
Red indicates 33D1, green indicates CD169, and
blue indicates CD11c antibodies. Scale bar,
100 mm. Dotted line demarcates the T cell zone
(TCRb).
(B–E) Fluorescence images of serial sections from
one spleen from a naive wild-type mouse demon-
strating distinct DC subset regions. Dotted lines
demarcate the T cell zone (see Figures S1B and
S1C). (B) Red indicates 33D1, green indicates
CD169, and blue indicates CD11c. Scale bar,
500 mm. (C) Red indicates XCR1, green indicates
CD169, and blue indicates CD11c. Scale bar,
500 mm. (D) Red indicates 33D1, green indicates
CD169, and blue indicates CD11c. Scale bar,
100 mm. (E) Red indicates XCR1, green indicates
CD169, and blue indicates CD11c. Scale bar,
100 mm. A representative spleen from 18 different
WT mice. RP, red pulp; WP, white pulp; BC,
bridging channels; MZ, marginal zone.
See also Figures S1B and S1C.
(Hendrickson et al., 2011). In this model,
RBC alloimmunization is CD4+ T cell
dependent, and requires 33D1+ DCs for
CD4+ T cell activation and subsequent
antibody induction (Calabro et al., 2016).
We used i.v. immunization with these
two forms of antigen to address the
relative roles of the primary cDC subsets
in the spleen in regulating adaptive
immunity.
We adapted a flow-cytometry-based
methodology to first identify the gross
location of particular DC subsets pre/
post-RBC transfusion using in vivo intra-
vascular antibody labeling immediately
before harvesting spleen samples (Ander-
son et al., 2014). This allowed us to track the movement within
the spleen of both 33D1+ and XCR1+ DCs from the antibody-
accessible RP to antibody-inaccessible WP (Figure 2A). We
confirmed by immunofluorescence that intravascular anti-
CD11c antibody stained only DCs located in the RP/MZ and in
the outer rim of the bridging channel, but not those located in
the WP (Figure 2B). In naive mice, we found that almost 60%
of 33D1+ and 70% of XCR1+ DCs were outside of the WP at
steady state (Figure 2A). Our previous work demonstrated that
transfused GFP+ RBCs were excluded from theWP immediately
after transfusion (Calabro et al., 2016). By transfusing GFP-
labeled RBCs, we could, thereby, track antigen-carrying DCs
into the WP and found that the majority of 33D1+ and XCR1+
DCs migrated into the WP, including those carrying RBCs.
Similar results were found following LPS infusion (data not
shown). Mass DC migration in transfused mice was also evi-
dent by the loss of immunofluorescence staining of intravas-
cular-bound anti-CD11c (Figure S2B, lower panel), as compared
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with the naive state, which demonstrates extensive staining in
the MZ, RP, and bridging channel (Figure S2B, upper panel).
Therefore, i.v. immunization induces mass DC migration of
both antigen-positive and -negative DCs into the T cell zone of
the WP.
We then evaluated the location of 33D1+ and XCR1+ DCs by
immunofluorescence in wild-type mice transfused either with
RBCs or LPS over time. Four hours after immunization, 33D1+
DC migration commences from the bridging channel, and
6–8 hr after immunization, most 33D1+ and a large fraction of
XCR1+ DCs migrate to the T cell area. Strikingly, these two DC
subsets migrated into non-overlapping regions of the T cell
area of the WP (Figures 2C, 2D, and S2C). The 33D1+ DCs
migrated to the periphery of the T cell zone and remained near
the border of the B cell area. In contrast, XCR1+ DCs migrated
from the MZ/RP into the center of the T cell zone. Measurement
of the average distance of all DCs within each subset to the
Figure 2. 33D1+ and XCR1+ DCs Migrate
into Distinct Regions of the T Cell Zone
following Immunization
(A) Tracking of 33D1+ (top) or XCR1+ (bottom)
splenic DCs into the white pulp (WP) before (naive)
or 6–8 hr after (+RBC) transfusion with GFP+
RBCs, using in vivo labeling. Injection of anti-
CD11c i.v. 3 min before sacrifice marks DCs in the
red pulp (RP) but not the WP. DCs that have
phagocytosed RBCs are GFP+.
(B) Fluorescence image of a spleen from a naive
wild-type mouse transfused 3 min prior to sacrifice
with anti-CD11c (white overlay). Red indicates
33D1, green indicates CD169, and blue indicates
CD11c in vitro stain. Scale bar, 100 mm.
(C and D) Fluorescence image from a section of an
entire spleen from a wild-type mouse transfused
with RBCs 6–8 hr earlier, demonstrating the dif-
ferential location of 33D1+ (left) or XCR1+ (right)
DCs (red). Green indicates CD169, and blue in-
dicates CD11c. Scale bars, 500 mm.White box
highlights the regions in (D) showing a single white
pulp. 33D1+ (top) and XCR1+ (bottom) DC stain-
ing. (Right) T cell zone is demarcated by an overlay
of TCRb (white). Scale bars, 100 mm. Representa-
tive spleen from one of three mice in seven inde-
pendent experiments.
(E) Images of DC subsets within 16 distinct WPs
from five independent experiments were analyzed
by Imaris software to determine the average dis-
tance of DC centroids to the WP border as defined
by location of MOMA-1+ cells. Each data point
represents the average distance of all 33D1+
(squares) or XCR1+ (circles) DCs within an indi-
vidual MOMA-1 ring. ***p < 0.001.
MOMA-1 ring across multiple spleens
confirmed that 33D1+ DCs are located
proximally to the MZ, whereas XCR1+
DCs are located distally to the MZ (Fig-
ure 2E). 12 hr after immunization, both
33D1+ and XCR1+ DCs completed
migration, and at around 16 hr, both the
MOMA-1+ ring (Gaya et al., 2015) and
33D1+ DC staining began to dissolve. Simultaneously, some
33D1+ staining began to appear in the bridging channel and
XCR1+ staining began to appear in the RP, consistent with
observed turnover rates by bromodeoxyuridine (BrdU) studies,
suggesting the influx of newDC populations to their steady-state
locations (data not shown) (Kamath et al., 2000). These results
demonstrate that, after immunization, both 33D1+ and XCR1+
DCsmigrate into the T cell area but segregate into distinct zones.
The Location of Each DC Subset Corresponds to the T
Cell Lineage Preferentially Primed by that Subset
Given the known preferential activation of CD4+ versus CD8+
T cells by 33D1+ versus XCR1+ DCs, respectively, we assessed
the location of the two T cell lineages in comparison with each
DC subset in adjacent spleen sections following immunization.
Use of CD8b allowed us to label all CD8+ T cells, but not DCs,
which express a CD8aa homodimer. TCRb+CD8b (Figure 3A)
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or TCRb+CD4+ co-staining (Figure 3B) was used to identify
CD4+ T cells. Analysis revealed that the two T cell lineages
occupy preferential domains within the T cell zone at steady
state and after immunization (Figures 3A and B; Figure S3A).
CD4+ T cells formed a ring concentrated at the periphery of
the T cell zone along the B cell border. In contrast, CD8+
T cells were concentrated in the center of the T cell zone, often
surrounding the central arteriole. Intensity analysis of CD4 versus
CD8b staining within a single WP highlighted the gradient of
T cell lineages (Figures 3C and S3B). Simultaneous analysis of
DC subsets in this same WP demonstrated that the 33D1+ DC
location coincided with the most intense CD4+ T cell staining;
in contrast, XCR1+ DCs from the same region coincided with
the highest CD8b+ T cell staining (Figures 3B and S3A). This
cellular organization after immunization places each DC subset
in proximity to the T cell that it is known to prime most efficiently.
To gauge the importance of this co-localization to adaptive im-
munity, we disrupted DC subset and T cell pairing using Ccr7-,
Batf3-, and Dock8-deficient mice.
Cell-Intrinsic CCR7 Is Crucial for DC Migration within
the Spleen, and Its Loss Results in Disorganized DC and
T Cell Co-localization
CCR7 is needed for T cells to homeproperly to T cell zoneswithin
both LNs and the spleen (Braun et al., 2011). It is also required for
peripheral DCs to home to LNs (Fo¨rster et al., 1999; Ohl et al.,
2004). The role of CCR7-directed DCmigration within the spleen
is less clear, with different studies drawing opposite conclusions
(Czeloth et al., 2005; Gunn et al., 1999; Junt et al., 2004; Ritter
et al., 2004; Yi and Cyster, 2013). We found that T cells in
Ccr7/ mice were scattered throughout the RP, analogous to
the mislocalized T cells identified in LNs from these mice (Fig-
ure 4A; Figure S4A) (Fo¨rster et al., 1999). Although Ccr7/
mice had a normal percentage of both total DCs and DC subsets
(data not shown), all DCs were scattered around the RP and
lacked structured organization in bridging channels andMZ rings
(Figure 4A). Upon immunization, Ccr7/ DCs failed to move in-
side the MOMA-1 ring (Figures 4A and S4A). Accordingly, there
was a lack of 33D1+ and XCR1+DCmigration into the respective
areas of the T cell zone after immunization (Figure S4B). To
determine whether this was due to lack of CCR7 expression on
DCs or simply a disorganized splenic structure, we created
mixed bone marrow chimeras from CD11c-YFP (yellow fluores-
cent protein) and Ccr7/ mice. In these chimeras, YFP+ DCs
express CCR7, while YFP DCs lack CCR7. Anti-CD11c in vivo
labeling revealed that Ccr7-deficient DCs failed to migrate into
WP, as compared with wild-type YFP+ DCs (Figure 4B). These
data indicate that cell-intrinsic CCR7 expression is essential for
intrasplenic DC migration.
To test the immunological consequence of impaired DC
migration in Ccr7/ mice and a disorganized niche for DC sub-
set-T cell interactions, we adoptively transferred Ccr7-sufficient
transgenic OT-II T cells that carry an OVA-specific, MHCII-
restricted T cell receptor into wild-type and Ccr7/ mice.
OVA-expressing HOD RBCs were transfused into recipient
mice 24 hr later and T cell proliferation was assessed by CFSE
dilution after 3 days. In contrast to wild-type recipients, OT-II
proliferation inCcr7/mice was almost completely absent (Fig-
ure 4C). In this model, CD8+ T cells are not significantly acti-
vated; therefore, we tested transgenic CD4+ (OT-II) and CD8+
(OT-I) T cell activation, using i.v. soluble OVA with the DC matu-
ration stimulus LPS. OVA induced significant activation of both
OT-I and OT-II cells in wild-type mice, but this was significantly
impaired in Ccr7/ mice (Figure 4D). These findings indicate
that, even if DCs and T cells occupy the same general area within
the spleen, it is insufficient to induce T cell activation unless line-
age-specific spatial organization is achieved.
XCR1+ DCs Are Required for CD8+, but Not CD4+, T Cell
Activation, but Only In Vivo
We showed that different DC subsets co-localize with their
respective T cell subsets within subdomains of the T cell zone
(Figure 3) and that disruption of DC-T cell niches impairs subse-
quent adaptive immunity (Figure 4). However, Ccr7 deficiency
impairs overall splenic architecture, making delineation of the
isolated role of each DC subset difficult. To evaluate DC subset
function in vivo, one approach is to target antigen to a DC sub-
set-specific surface receptor, such as DEC205 (Dudziak et al.,
2007), but this can also deliver antigen to unintended DCs (Kam-
phorst et al., 2010). Another approach is to inject antigen in vivo
and sort DCs to stimulate T cells in vitro (Pooley et al., 2001;
Schnorrer et al., 2006). This ex vivo system evaluates the ability
of a DC to phagocytose and present antigen but does not neces-
sarily correlate with the ability to activate a T cell in vivo. Indeed,
both DC subsets can activate CD4+ and CD8+ T cells in vitro for
most types of antigens, albeit with different efficiency, implying
that restricted processing of antigen on either MHCI or MHCII
does not sufficiently explain the in vivo preferences observed
for T cell lineage activation (Itano and Jenkins, 2003; Lewis
et al., 2011; Schulz and Reis e Sousa, 2002).
The recent development of mice lacking DC-lineage-specific
transcription factors has enabled the evaluation of the in vivo
role of specific DC subsets (Satpathy et al., 2012). We took
advantage of Batf3/ mice, which are deficient in the basic
leucine zipper transcription factor 3 (Batf3), to evaluate the role
of XCR1+ DCs on instructing its corresponding CD8+ T cell line-
age. Batf3/mice have a selective loss of CD8aa+XCR1+ DCs
in the spleen and have defects in mounting antigen-specific
CD8+ T cell responses to viral infections or cell-associated anti-
gens (Hildner et al., 2008; Seillet et al., 2013) (Figure 5A). Whether
cross-presentation of soluble antigens is impaired in Batf3/
mice is unclear, as a recent study showed that CD8+ T cell acti-
vation was impaired in Batf3-deficient mice with particulate, but
not soluble, antigen (Seillet et al., 2013). To test the impact of
XCR1+DC loss on both CD4+ andCD8+ T cells in vivo, we adop-
tively co-transferred CFSE-labeled OT-I and OT-II T cells into
wild-type and Batf3/ recipient mice. Three days after OVA/
LPS immunization (i.v.), we observed a dramatic loss of CD8+,
but not CD4+, T cell activation in Batf3/ mice (Figure 5B).
During chronic inflammation, compensatory transcription fac-
tors can partially rescue CD8aa+ XCR1+ DC development and
might rescue the ability to prime CD8+ T cells (Tussiwand
et al., 2012); therefore differences in CD8+ T cell activation
observed between studies might relate to a complete versus
partial loss of XCR1+ DCs in the mice used. Given that we found
an almost complete absence of XCR1+ DCs in naive Batf3/
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Figure 3. 33D1+ and XCR1+ DCs Co-localize with CD4+ and CD8+ T Cells, Respectively
(A) Fluorescence image of a spleen from a naive wild-type mouse. Red indicates CD8b, green indicates TCRb, and white indicates CD169. Scale bar, 500 mm.
Representative spleen from eight independent experiments.
(B) Fluorescence images of a single follicle of a spleen from a mouse 6–8 hr after challenge i.v. with 25 mg LPS. Left panel: red indicates 33D1, green indicates
CD169, and blue indicates CD11c. Middle panel: red indicates XCR1, green indicates CD169, and blue indicates CD11c. Right panel: red indicates CD8b, green
indicates TCRb, blue indicates CD4; and white indicates CD169. Dotted line indicates T cell region. Scale bars, 100 mm. Representative spleen from six inde-
pendent experiments.
(legend continued on next page)
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mice by immunofluorescence and by flow cytometry (Figure 5A)
and that CD8+ T cell responses were abrogated in vivo (Fig-
ure 5B), we tested whether the remaining splenic DCs could
cross-present soluble protein by performing an in vitro T cell
stimulation assay. Splenic DCs from wild-type and Batf3/
mice co-cultured with OT-I or OT-II cells in vitro induced activa-
tion of both T cell lineages (Figure 5C), further demonstrating that
CD8+ T cell activation in vivo requires XCR1+ DCs, despite the
ability of 33D1+ DCs to cross-present soluble antigens (Hildner
et al., 2008). This suggests that the location of a DC subset in vivo
might dictate whether it can present antigen to a CD4+ or CD8+
T cells. This work also suggests that experiments conducted
ex vivo that bypass differential cellular locations within second-
ary lymphoid regions provide a limited picture of DC-T cell
interactions.
33D1+ DCMigration in the Spleen Is Required for CD4+,
but Not CD8+, T Cell Activation
Mice lackingDock8 (Dedicator of cytokinesis 8), an atypical gua-
nine nucleotide exchange factor that regulates Rho GTPases,
have impaired DC migration to LNs that results in loss of CD4+
T cell activation to subcutaneous immunization (Harada et al.,
2012; Krishnaswamy et al., 2015). In vivo labeling of splenic
DC location demonstrated that Dock8/ mice have only
partially impaired DC migration into the WP after RBC transfu-
sion (Figure 6A) or LPS (data not shown). Immunofluorescence
visualization revealed that only one of the two DC subsets failed
to migrate. Although the location of the two DC subsets is not
altered at steady state (data not shown), following immunization,
33D1+ DCs remained in bridging channels, while the majority of
XCR1+ DCs migrated normally into T cell zones (Figures 6B and
S5A). Using in vivo labeling to detect migration of each of the two
DC subsets into the WP, we indeed found that XCR1+, but not
33D1+, DCsmigrated into theWPafter immunization (Figure 6C).
To test whether this selective 33D1+ DC migration defect
impacted CD4+ or CD8+ T cell activation, we adoptively co-
transferred CFSE-labeled OT-I and OT-II T cells into wild-type
and Dock8/ mice and tested the immune response to OVA
i.v. Systemic OVA administration failed to induce antigen-spe-
cific CD4+ T cell proliferation, while CD8+ T cell responses re-
mained intact (Figure 7A). Therefore, CD4+ T activation was
impaired in Dock8/, mice despite intact XCR1+ DC migration,
suggesting non-redundancy between these two cDC subsets in
T cell lineage activation in vivo. In the absence of 33D1+ DC
migration into WP, antigen-specific CD4+ T cell proliferation
was also completely abrogated to allogeneic RBCs in Dock8/
mice (Figure 7B). Accordingly, T-dependent induction of alloan-
tibodies was also impaired (Figure S5B). However, in addition to
failed DC migration, Dock8/ mice lack MZ B cells and have
intrinsic defects in the function of T and B cells (Krishnaswamy
et al., 2015; Randall et al., 2009), thus confounding interpretation
of failed antibody responses. To exclude the role of other cell
types, we generatedDock8//Zbtb46-DTRmixed bonemarrow
chimeras. Zbtb46-DTRmice express the diphtheria toxin (DT) re-
ceptor in cells that express the zinc finger transcription factor
ZBTB46 (Meredith et al., 2012). In these chimeric mice, after
DT treatment, T and B cells develop normally, including MZ B
cells, but cDCs are exclusively Dock8 deficient (Figures S5C
and S5D). This allowed us to specifically study 33D1+ DC func-
tion during alloimmune responses to transfused RBCs. Three
weeks after allogeneic RBC transfusion, DT-treated Dock8//
Zbtb46-DTR mice failed to generate alloantibodies, whereas
control mice mounted a robust response (Figure 7C). Therefore,
mislocalized 33D1+ DCs are unable to initiate a T-dependent B
cell antibody response.
Using the RBC alloimmunization model, we conclude that
migration of RBC-carrying XCR1+ DCs (Figure 2A) into the WP
(Figure 6B) is insufficient for CD4+ T cell activation (Figure 7A),
potentially because these DCs are primarily co-localized with
CD8+ instead of CD4+ T cells (Figure 3). These results also imply
that simple differences in antigen presentation on MHCI versus
MHCII does not solely account for the DC division of labor. These
findings provide compelling evidence that efficient adaptive im-
mune responses rely on specific spatial distributions within
lymphoid tissues.
DISCUSSION
We demonstrate the existence of a dynamic architecture of im-
mune cells in the spleen that regulates T and B cell responses
to blood-borne antigens. Although DC movement within the
spleen after activation has long been appreciated, it was not
recognized that the two major DC subsets segregate into non-
overlapping regions or, surprisingly, that CD4+ and CD8+
T cells form a cellular gradient across the T cell zone at steady
state. 33D1+ DCs migrate into the CD4+ T cell area, and
XCR1+ DCsmigrate into the CD8+ T cell area of the WP (Figures
2 and 3), uncovering the existence of both T cell lineage niches
and the intricate orchestration of DCmigration within the spleen.
Accordingly, if 33D1+ DC migration into the T cell zone is abro-
gated (in Dock8-deficient mice), CD4+ T-cell-dependent im-
mune responses to blood-borne antigens are lost, but CD8+
T cell activation is unimpaired (Figures 6 and 7). Conversely,
loss of XCR1+ DCs in Batf3-deficient mice impairs CD8+ T cell
activation in vivo while strikingly leaving CD4+ T cell activation
intact (Figure 5). However, simply having DCs and T cells occu-
pying overlapping but disorganized regions of the spleen is
insufficient to generate T cell activation, as demonstrated by ex-
periments using Ccr7-deficient mice (Figure 4). We used two
different types of stimulation to induce segregated DCmigration
into the WP, including LPS and transfused allogeneic RBCs; our
ongoing work using a range of immune stimuli, including sys-
temic live viral infection, replicates these findings (data not
shown), suggesting that this is a universal phenomenon. Simi-
larly, we chose OVA/LPS and allogeneic RBCs to study differen-
tial activation of CD4+ and CD8+ T cells, but we also observe the
(C) Follicle shown in (B) demonstrating the single stain for CD4 (left) or CD8b (middle) with the CD169 ring (green) overlaid. Right panel: histogram showing relative
intensity of a cross-section of the CD4 versus CD8b staining (see Figure S3). Below each image is a 3D surface plot displaying relative staining intensity. The x and
y axes represent image coordinates, and the z axis represents the relative luminance of each pixel. Scale bar, 100 mm.
See also Figure S3.
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Figure 4. Cell-Intrinsic CCR7 Is Crucial for DC Migration within the Spleen and Subsequent T Cell Activation
(A) Fluorescence image of a spleen from wild-type (WT) and Ccr7/ mouse without transfusion (naive) or 6–8 hr after RBC transfusion (+ RBC). Red indicates
B220, green indicates CD169, blue indicates CD11c, and white overlay indicates TCRb. RP, red pulp; WP, white pulp. Scale bars, = 200 mm. n = 2–3 mice per
group. Representative of three independent experiments.
(B) CD45.1 mice were irradiated and reconstituted with amixture of bonemarrow cells fromCD11c-YFP (50%) and wild-type orCcr7/ (50%)mice. Eight weeks
later, chimeric mice were injected i.v. with 15 mg LPS or PBS. 6–8 hr later, in vivo labeling was used to track the migration of splenic DCs into the white pulp. (Top)
Flow cytometry plots of splenic DCs, with gates indicating DCs outside of the WP; blue indicates wild-type DCs, and red indicates Ccr7/ DCs. (Bottom)
Percentage of DCs outside of white pulp (WP) in the presence or absence of LPS treatment in each group. *p < 0.05; ns, not significant; results representative of
three independent experiments. Error bars indicate SD.
(legend continued on next page)
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same pattern of selective loss of CD4+ or CD8+ T cell activation
with other forms of antigen, including heat-killed Listeria mono-
cytogenes (data not shown), again arguing that this model ap-
plies to a wide range of immune responses. Therefore, establish-
ment of niches of T cell lineages with their corresponding DC
subsets appears to be a fundamental step in the generation of
an efficient T cell response.
How is this differential migration achieved? Fibroblastic
reticular cells (FRCs) are present in the bridging channel and
T cell zone and are thought to act as ‘‘roads’’ in the spleen, di-
recting lymphocyte migration (Baje´noff et al., 2008; Steiniger
et al., 2001). FRCs are lined by the CCR7 ligand CCL21, which
acts to guide T cells into the WP. Although it is not known
whether they similarly direct activated DCs within the spleen,
they are crucial for directing peripheral tissue DCs into and
within LNs (Acton et al., 2012). Our demonstration of a DC-
intrinsic CCR7-dependent pathway regulating DC orchestra-
tion (Figure 4B) suggests that a similar situation might exist
in the spleen but cannot explain the differential DC subset
segregation we observed. The XCR1 ligand, XCL1, is made
by activated CD8+ T cells and presumably helps localize
XCR1+ DCs during an immune response (Crozat et al., 2011;
Dorner et al., 2009), it but might only act at later time points
during an ongoing immune response. Sphingosine-1-phos-
phate (S1P) and EBI2 (GPR183) both have been shown to
direct 33D1+ DCs to the bridging channel; disruption of either
by pharmacological inhibitors or genetic deletion impairs DC
organization and capture of particulate antigen from the
bloodstream (Czeloth et al., 2005; Gatto et al., 2013; Yi and
Cyster, 2013). Future work will need to determine whether a
balanced combination of these and other localization signals
determine both the steady-state and post-immunization DC
positions, as has been shown for naive versus activated B
cells in the spleen (Reif et al., 2002).
Recent work on DC subsets and their interactions with T cells
in LNs following viral infection found that initial activation of
CD4+ versus CD8+ T cells was spatially segregated, and this
segregation correlated with the location of migratory versus
LN-resident DCs (Eickhoff et al., 2015; Hor et al., 2015).
Whether the two migratory DCs segregated once reaching
the LN was not analyzed. Furthermore, XCR1 staining was
used to identify LN-resident DCs, which marks both migratory
CD103+ and LN-resident CD8+ DCs (Crozat et al., 2011).
Therefore, it is difficult to know whether XCR1+ DCs in LNs af-
ter infection are derived from tissue migratory DCs, LN-resident
DCs, or both. Nevertheless, XCR1+ DCs in the LN were shown
to activate CD8+ T cells during a viral infection and, interest-
ingly, at later time points (>30 hr), to also co-localize with
CD4+ T cells. Future work analyzing the relative location of
CD4+ versus CD8+ T cells in the spleen as the immune
response ensues will be important to determine whether
T cell segregation dissipates as the immune response evolves
(Gerner et al., 2015); in order to access CD4+ T cell help for
DC licensing and fulminant CD8+ T cell activation, it is possible
that CD4+ T cells leave the peripheral T cell zone, as identified
in our work, and migrate to an XCR1+ DC subset, where we
show CD8+ T cells are concentrated. Whether T cell segrega-
tion exists at the steady state in LNs has not been addressed,
but given our direct evidence for subdomain organization in the
spleen between DC subsets and T cell lineages, we propose
that this pattern might be universal across all secondary
lymphoid organs.
Although human and murine splenic architecture is different
in a number of respects, the basic principle of DC subset
segregation and then re-organization to promote appropriate
adaptive immune responses is likely to be conserved (Pack
et al., 2008; Steiniger et al., 2001). DC subsets with overlapping
markers and function exist in both species (Mittag et al., 2011).
Future work will examine whether similar DC subset segrega-
tion exists within human spleens. If this proves to be the
case, interventions aimed at blocking DC migration might
ameliorate unwanted immune responses, such as those to
allogeneic RBC transfusion. Despite matching the ABO blood
group antigens, alloimmunization rates approach 45% in
chronically transfused patients, such as those with sickle cell
disease or thalassemia (Vichinsky et al., 1990). We previously
demonstrated that 33D1+ DCs were required for inducing
CD4+ T-cell-dependent RBC alloimmunization using Irf4-defi-
cient mice lacking this DC subset (Calabro et al., 2016). How-
ever, we also found that both XCR1+ and 33D1+ DCs phagocy-
tose transfused RBCs, so it was not clear why XCR1+ DCs
could not compensate to activate CD4+ T cells. Our finding
of segregated 33D1+ and XCR1+ DC subsets within the
T cell zone after RBC transfusion suggests that XCR1+ DCs
are, in fact, in the wrong location to induce CD4+ T cell priming
to RBC antigens. Accordingly, we now demonstrate that just
the loss of 33D1+ DC migration into the T cell zone in Dock8-
deficient mice is sufficient to prevent the induction of RBC allo-
antibodies. This suggests that blocking DC migration therapeu-
tically during prophylactic RBC transfusion could ameliorate the
potentially life-threatening impact of alloantibodies in patients
who require lifelong RBC support.
We propose a unified model of DC function in regulating T cell
immunity. Upon activation by an innate immune stimulus, DC
migration from the ’’peripheral tissue’’ of the spleen (MZ and
RP) to the ’’lymph node’’ of the spleen (WP) follows the classic
rules now well established for other tissues: DC maturation in-
cludes upregulation of CCR7, which directs mature DCs into
the T cell zone of the WP (Figures 2 and 4). This relocalization
to the T cell area is clearly dependent on innate immune stimuli
such as LPS, although how stored allogeneic RBCs trigger
innate immune receptors is still under investigation (Gibb et al.,
(C) Wild-type and Ccr7/ mice received 106 CFSE-labeled CD45.1+CD4+ OT-II cells. 24 hr after T cell transfer, mice were transfused with HOD RBCs, and
proliferation in the spleen was measured by CFSE dilution in wild-type (blue) and Ccr7/ (red) mice 3 days after RBC transfusion.
(D) CFSE-labeled purified CD45.1+ naive 106 OT-I (CD8+ T cells) and 106 OT-II (CD4+ T cells) were co-transferred into naive wild-type andCcr7/mice, and 1 day
later, the recipient mice were immunized i.v. with 5 mg OVA with 1 mg of LPS. (Left) Three days later, OT-I and OT-II proliferation was assessed in the spleen by
measuring CFSE dilution by flow cytometry. Proliferation gates were set using unimmunizedmice. (Right) Percentage of OT-I andOT-II T cells proliferated in each
group. *p < 0.05; **p < 0.01; results are representative of five independent experiments. Error bars indicate SD.
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2016). This paradigm, then, would hold universally true for all
migratory DCs and all naive T cell responses, regardless of the
site of antigen encounter. Furthermore, it suggests that inappro-
priate immune responses to systemic antigens are avoided
by setting a threshold for T cell activation in the spleen by re-
stricting antigen exposure to migrated DCs, analogous to what
Figure 5. XCR1+ DCs Are Required for CD8+, but Not for CD4+, T Cell Activation Only In Vivo
(A) Fluorescence image of spleens from wild-type (WT) (left) and Batf3/ (middle) mice 6–8 hr after injection i.v. of 15 mg of LPS. Red indicates XCR1, green
indicates CD169, and blue indicates CD11c. Scale bar, 100 mm. (Right) Quantitation of number of XCR1+ DCs in the spleen of naive wild-type versus Batf3/
mice by flow cytometry. Less than 2% of all DCs in the spleen of Batf3/mice expressed XCR1. ***p < 0.001; n = 2–3 mice per group. Representative of three
independent experiments. Error bars indicate SD.
(B) 106 CFSE-labeled CD45.1+ OT-I and OT-II cells were co-transferred into wild-type and Batf3/mice, and 24 hr later, mice were immunized i.v. with 5 mg OVA
with 1 mg of LPS. Three days later, OT-I and OT-II proliferation was assessed by measuring CFSE dilution by flow cytometry. (Bottom) Percentage of OT-I and
OT-II T cells proliferating in the spleen in groups of wild-type and Batf3/ mice after immunization **p < 0.01; ns, not significant. n = 2–3 mice per group.
Representative of six independent experiments. Error bars indicate SD.
(C) Splenic DCs fromwild-type or Batf3/mice were enriched byMACS purification. After pulsing with 100 mg/ml OVA for 1 hr at 37C, the purified DCs were co-
cultured with CFSE-labeled purified OT-I and OT-II T cells for 72 hr, respectively. OT-I and OT-II proliferation was assessed by measuring CFSE dilution by flow
cytometry. Numbers indicate the percentage of proliferating cells in the indicated gates. Representative of two independent experiments. (Bottom) Percentage of
OT-I and OT-II T cells proliferating in vitro after co-culture with pulsed wild-type or Batf3/ DCs. ns, not significant. Error bars indicate SD.
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Figure 6. Selective Splenic 33D1+ DC Migration Defect in Dock8-Deficient Mice
(A) Wild-type (WT) and Dock8/mice were transfused with HOD RBCs. (Left) 6–8 hr later, in vivo labeling was used to track the migration of splenic DCs into the
white pulp (WP). DCs were analyzed in wild-type and Dock8/mice before (naive) or after (+RBCs) RBC transfusion. (Right) Pooled percentages of DCs outside
of WP of wild-type and Dock8/ mice before or after RBC transfusion from three separate experiments. ***p < 0.001. Error bars indicate SD.
(B) Fluorescence images of spleens from wild-type (top) and Dock8/ (bottom) mice 6–8 hr after RBC transfusion. Red indicates 33D1 or XCR1, green indicates
CD169, and blue indicates CD11c. T cell area (from TCRb stain) outlined to assess DCmigration into the T cell zone (dotted line). Arrows highlight the presence of
33D1+DCs inside the T cell zone of wild-type, but notDock8-deficient, mice (left). Arrows highlight the presence of XCR1+ DCs inside the T cell zone of both wild-
type and Dock8-deficient mice (right). Scale bars, 500 mm. n = 2–3 mice per group. Representative of six independent experiments.
(C) Average ratio of percentage of DCs inside:outside of WP of either 33D1+ (left) or XCR1+ (right) DCs in naive (gray) or RBC transfused (black) mice. Shown is
one representative experiment of three. n = 2–4 mice per group. *p < 0.05; ns, not significant. Error bars indicate SD.
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is proposed in the periphery. The kinetics of DC migration we
observed into the splenic T cell zone is similar to that observed
in the LNs of intra-lymphatically injected DCs; once DCs reach
the sub-capsular sinus of a LN, it takes less than 12 hr to migrate
into the inner T cell zone (Braun et al., 2011). Oncemigrated, both
DC subsets can process antigen for MHCI or MHCII, but 33D1+
DCs preferentially interact with CD4+ T cells in one region of the
T cell zone, and XCR1+ DCs interact with CD8+ T cells in a
different region. These findings suggest a developing paradigm
in which specialized migratory DC subsets preferentially interact
in domains enriched for CD4+ or CD8+ T cells in the spleen and
LNs to selectively promote adaptive immune responses.
EXPERIMENTAL PROCEDURES
Mice
C57BL/6micewere purchased fromCharles River Laboratories.Dock8/ and
HODmicewere previously described (Hendrickson et al., 2011; Krishnaswamy
et al., 2015); OT-I, OT-II, CD11c-YFP, UBC-GFP, Batf3/, and Ccr7/ mice
were purchased from The Jackson Laboratory. All protocols used in this study
were approved by Yale Institutional Animal Care and Use Committee.
Immunofluorescence Analysis
Fresh splenic tissue was dehydrated through sequential exposure to solu-
tions of 10%, 20%, and 30% sucrose; mounted in a cryomold with OCT
(optimal cutting temperature) compound (Tissue-Tek, Sakura); and stored
at 80C prior to 7-mm sectioning and staining. The following antibodies
were used for staining different cell subsets: CD11c (N418), 33D1 (33D1),
XCR1 (ZET), CD169 (MOMA-1), TCRb (H57-597), CD8b (YTS156.7.7), CD4
(RM4-5), and B220 (RA3-6B2). The images were acquired immediately after
staining with the Nikon Eclipse Ti microscope using either 43 or 203
objectives.
Intravascular Antibody Labeling
Mice were injected i.v. with 15 mg LPS or 1 U of HOD RBCs. At 6–8 hr later,
1.5 mg of anti-CD11c-APC was injected i.v. Three minutes later, the mice
were sacrificed, and spleens were collected in cold PBS. To obtain optimal
DC staining for injected antibodies, we prepared single-splenocyte suspen-
sion by mechanically chopping the spleens.
RBC Transfusion Model
RBCs were collected from HOD transgenic mice in 12% CPDA-1 anticoagu-
lant and leukoreduced using a Pall neonatal filter, followed by 4C storage
for 12 days (Hendrickson et al., 2011). Before transfusion, the RBCs were
washed by centrifugation, and the packed RBCs were diluted 1:2 with sterile
PBS; 200 ml diluted bloodwas transfused i.v. into recipientmice (the equivalent
of 1–2 U human RBCs). A dilution of 1:2 was used for alloantibody induction or
ex vivo antigen presentation, and a ratio of 1:20 was used for in vivo OT-II
proliferation.
Statistical Analysis
All statistical analyses were performed using Prism (GraphPad Software). Data
were analyzed with the unpaired t test using Welch’s correction.
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(A) Wild-type (WT) andDock8/mice received 106
CFSE-labeled CD45.1+CD4+ OT-II cells and
CD45.1+CD8+ OT-I cells. 24 hr later, mice were
immunized i.v. with 5 mg of OVA with 1 mg LPS, and
proliferation in the spleen was measured by CFSE
dilution by gating on CD45.1+ OT-I or OT-II cells,
respectively. (Left) Numbers indicate the percent-
age of proliferating cells in the indicated gates.
(Right) Proliferation of OT-I and OT-II T cells in the
spleens of each group of wild-type or Dock8/
mice after immunization. **p < 0.01; ns, not sig-
nificant; representative of six independent experi-
ments. Error bars indicate SD.
(B) Wild-type and Dock8/ mice received 106
CFSE-labeled CD45.1+CD4+ OT-II cells. 24 hr
later, mice were transfused with HOD RBCs, and
OT-II proliferation in the spleen was measured by
CFSE dilution 3 days later in wild-type (blue) and
Dock8/ (red) mice. Representative of four inde-
pendent experiments.
(C) Anti-RBC antibodies in the sera of Zbtb46-
DTR/ Dock8/mixed bone marrow chimeric mice
with or without treatment with diphtheria toxin (DT)
21 days following HOD RBC transfusion. Zbtbt46-
DTR bone marrow was mixed 1:1 with either C57BL/6 (WT) or Dock8/ (KO) bone marrow as indicated. Zbtbt46-DTR/KO chimeric mice administered DT have
only Dock8-deficient DCs during RBC transfusion. Each dot represents an individual mouse. ****p < 0.0001. n = 6–9 mice per group. Representative of three
independent experiments. Error bars indicate SD.
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Supplemental Experimental Procedures 
 
Diphtheria toxin treatment. Diphtheria toxin (DT) was purchased from Sigma-Aldrich and titrated in Zbtb46-DTR bone 
marrow chimeric mice (due to variability between different lots). For transient DC depletion in Zbtb46-DTR bone marrow 
chimeric mice, 60ng of DT/gram of body weight was injected i.p. on day 0 followed by a second dose of 40ng of 
DT/gram on day two. For alloantibody experiments, HOD RBCs were transfused on day three. 
 
Flow cytometry Analysis and Antibodies. Single cell suspensions of spleen were acquired either with LSR II (BD), or 
MACSQuant (Miltenyi) flow cytometers and analyzed using FlowJo software (Tree Star). The following antibodies were 
used for staining different cell subsets (from BioLegend if not specified): TCRβ (H57-597), B220 (RA3-6B2), MHC II 
(M5/114.15.2), CD11c (N418), 33D1 (33D1), XCR1 (ZET), Va2 (B20.1), CD4 (GK1.5), Ly6C (HK1.4), Ly6G (1A8), 
F4/80 (CI:A3-1), CD11b (M1/70) and goat polyclonal anti-mouse Ig (BD Pharmingen). 
 
GFP-RBC uptake. GFP+ RBCs were collected from transgenic mice expressing enhanced Green Fluorescent Protein 
under the direction of the human ubiquitin C promoter, leukoreduced, and stored as described for HOD+ RBCs for 12 
days. Half an hour after RBC transfusion, the spleen was harvested and processed to obtain a single cell suspension. The 
uptake of GFP+RBCs was analyzed by flow cytometry in TCRβ- B220-MHC II+CD11c+) DC subsets.  
 
In vitro T cell proliferation assay. Splenic dendritic cells from WT or Batf3-/- mice were enriched by MACS isolation 
(Miltenyi Biotec) according to manufacturer suggested protocols. Purified DCs were plated at different numbers in a 96-
well round bottom tissue culture treated plate. After pulsing with 100ug/ml OVA for 1 hour at 37°C, free OVA was 
washed away. Then the DCs were co-cultured with CFSE labeled purified OT-I and OT-II T cells at different DC/T ratios 
for 72 hours. OT-I and OT-II proliferation was determined by CFSE dilution after gating on CD45.1+ CD8+ or 
CD45.1+CD4+ cells, respectively, by flow cytometry. Numbers on the histograms indicate the percentage of proliferating 
cells in the indicated gates. 
 
In vivo T cell proliferation assay. One million transgenic CD45.1+ CD4+ or CD8+ T cells, isolated from OT-II or OT-I 
mice were purified with the CD4+ or CD8+ negative isolation kit (Miltenyi Biotec or StemCell), CFSE labeled and 
adoptively transferred i.v. into recipient mice.  Twenty-four hours later, either 5ug of OVA (plus 1ug of LPS) or one unit 
of OVA-expressing HOD RBCs were injected. Three days after immunization spleens were collected and T cell 
proliferation was assayed by determining CFSE dilution of transgenic T cells by flow cytometry. 
 
Image analysis.  Imaris software was used to determine the distance of DC subsets from the WP border as defined by 
MOMA-1 staining. The contour of the WP boundary was defined manually using the inner surface of MOMA+ cells. The 
centroids of DC subsets were determined using the Imaris spots algorithm based on the fluorescent intensity of 33D1 or 
XCR1. The distance of each centroid within the while pulp to the nearest point of the WP boundary was determined using 
the Imaris XT “distance transformation” algorithm. Histograms and 3D surface plots of T cell staining were made in 
image J. 
 
Serum alloantibody analysis. Serum from transfused mice was collected three weeks after RBC transfusion. To identify 
the presence of alloantibodies, sera were added to 96 well plates coated either with 5uL of HOD+ RBCs or with 5uL of 
HOD- RBCs (negative control). After 30 minutes of incubation plates were washed and stained with anti-Ig conjugated 
with APC for 30 minutes. The stained samples were washed and the total Igs were analyzed by flow cytometry 
(Hendrickson et al., 2011). 
 
Transplantation. Wild type mice were irradiated with 2 doses of 650 rad three hours apart. Two hours after the second 
treatment, 106 bone marrow cells from Zbtb46-DTR mice were adoptively transferred by i.v. injection into wild type 
recipient mice. All experiments with bone marrow chimeric mice were performed 7-10 weeks after bone marrow 
transplant. 
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Figure S1: DC subset markers and distribution in spleens from naïve wildtype mice.
Related to Figure 1
(A) Representative flow cytometry images of splenic DC markers. Gated on TCRβ-CD19- cells that are MHCII+CD11c+ showing the 
distribution of the two dominant DC subsets with a variety of markers.  Also shown is the overlap of CD8 with XCR1 and CD4 with 33D1 
on splenic DCs. (B-C) The same spleen as in Figure 1B and Figure 1C with the T cell zone indicated by an overlay of TCR  (white). (B) 
33D1 (red); CD169 (green); CD11c (blue); TCR  (white). Scale bar = 500um. (C) XCR1 (red); CD169 (green); CD11c (blue); TCR  (white). 
Scale bar = 500um. One representative spleen of 3 from 6 independent experiments. 
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Figure S2:  RBC alloimmunization model and DC subset segregation in the white pulp with multiple stimuli. 
Related to Figure 2
(A) In vivo red blood cell (RBC) alloimmunization model. RBCs were collected from HOD transgenic mice, processed and stored in a 
similar manner as human RBCs are in the clinical setting and then transfused into recipient mice.
(B) Fluorescence image of a spleen from a naïve mouse (top) or a mouse transfused (bottom) with RBCs 6-8 hours prior to in vivo DC 
labeling with anti-CD11c (white). CD169 (green) staining performed after sacrifice. Arrows indicate area of DCs stained outside of the WP 
by anti-CD11c in vivo labeling (white). Scale bar = 100um. n = 2-5 mice/group. Representative of three independent experiments. (C) 
Fluorescence image of a single white pulp from a wildtype mouse transfused with 15μg of lipopolysaccharide (LPS) 4 hours prior, demon-
strating differential location of 33D1+ (left) and XCR1+ (right) DCs (red). CD169 (green); CD11c (blue).  Scale bar=100μm. Images are 
representative of five independent experiments with 2-3 mice/experiment. 
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Figure S3: CD4+ and CD8+ T cells occupy preferen-
tial niches in the T cell zone at steady state and after 
immunization. 
Related to Figure 3
(A) Fluorescence image of a spleen from a wildtype 
mouse 6-8 hours after i.v. injection of LPS. Upper panel 
shows CD8β (red), TCRβ (green) and CD169 (white); 
Middle panel shows 33D1 (red), CD169 (green) and 
CD11c (blue); Bottom panel shows XCR1 (red), CD169 
(green) and CD11c (blue).  Scale bar = 500um. Images 
are representative of three spleens tested across four 
independent experiments. (B) (Upper panel): Fluores-
cence staining shows CD4 (white, left) and CD8β 
(white, right) together with CD169 (green) of the same 
follicle, respectively. (Bottom panel): Histogram below 
the images showing relative intensity of a cross-section 
(blue box) of the CD4 (left) and CD8β staining (right).
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Figure S4: Subdomain organization of T cells, DCs and each DC subset is disrupted in the spleen of immunized Ccr7-deficient mice. 
Related to Figure 4
(A) Individual intensity images of TCRβ (left) or CD11c (right) in wildtype and Ccr7-/- mice 6-8 hours after RBC transfusion (from Fig. 4A). 
A clear loss of appropriate T cell and DC localization is observed in Ccr7-deficient mice, although significant overlap of the two disorganized 
populations exist. (B) Fluorescence image of a spleen from Ccr7-/- mouse without transfusion (naive, top) or 6-8 hours after RBC transfusion 
(+RBC, bottom). 33D1 or XCR1 (red); CD169 (green); CD11c (blue).  Scale bar = 500um. n = 2-3 mice/group. Representative of two 
independent experiments. 
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Figure S5: Intrasplenic 33D1+ DC migration is critical for allogeneic responses to transfused RBCs. 
Related to Figures 6 - 7
(A) Fluorescence image of the Dock8-/- spleen from Fig. 6b with the T cell zone demonstrated by an overlay of TCR staining (white). 33D1 
or XCR1 (red); CD169 (green); CD11c (blue). Scale bar = 500um. N = 2-3 mice/group. (B) Anti-RBC antibody in the sera of mice 21 days 
following HOD RBC transfusion in Dock8+/-, Dock8-/- and naïve mice. **P<0.002. n= 2-8 mice/group. Representative of three independent 
experiments. (C-D) Bone marrow chimera mice were generated using Zbtb46-DTR (CD45.1.2) and Dock8-/- (CD45.2) bone marrow in a 
50:50 ratio. Eight weeks after reconstitution, mice were (+DT) or were not (-DT) administered DT twice over a three-day period. Seven days 
after the final DT treatment, the presence of marginal zone B cells (C) or one day after the final DT treatment, the presence of DC subsets 
(D) was assessed by flow cytometry. No evidence of marginal zone B cell loss was observed (C). DT treatment eliminated all WT 
CD45.1.2+ (Zbtb46-DTR) DCs while leaving only CD45.2+ Dock8-deficient DCs in the spleen of mice receiving DT (D).  
